New award for naproxen tablets with radha pharmaceuticals. Period of performance is AUG 1, 2021 to JUL 31, 2022 with four one-year options.
Ended Indefinite Delivery Contract Awarded Last action
- Contract number
- 36E79721D0026
- Awardee
-
Radha Pharmaceuticals Inc. UEI C1S5SQ88KY67
- Awarding agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Task orders
- 0
Award facts
- Opportunity
-
- 6505--Naproxen Tablets (VA-21-00016254) Pre-Solicitation · 36E79721R0018 · Posted Jan 11, 2021
- 6505--Naproxen Tablets (VA-21-00016254) Effective 8/1/2021 - 7/31/2022 Award Notice · Posted Mar 29, 2021
- 6505--Naproxen Tablets (VA-21-00016254) Solicitation · Posted Jan 21, 2021
- Last date to order 100% complete
- IDV ceiling
- $13,398,314.55
- Award type
- Single award
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 3 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The National Acquisition Center, a civilian agency of the U.S. government, has awarded an Indefinite Delivery Contract (IDC) to Radha Pharmaceuticals Inc., a minority-owned small disadvantaged business manufacturer, to provide Naproxen tablets in various strengths and bottle sizes. The $13.4M ceiling value IDC has a base period of one year with four one-year option periods, allowing for an uninterrupted supply of an estimated 203,424 units annually to fulfill the medication requirements of the Department of Veterans Affairs, Department of Defense, Bureau of Prisons, and Indian Health Service. The award was made under full and open competition without any set-asides. The IDC leverages the VA and DoD Pharmaceutical Prime Vendor programs to efficiently distribute the Naproxen products to government medical facilities, securing reliable sourcing while obtaining discounted pricing for these high-volume generic pharmaceuticals.
The original solicitation, 36E79721R0018, was issued in a commercial item format under FAR Part 12. It sought proposals for a single-award IDC to provide Naproxen tablets in 250mg, 375mg, and 500mg strengths in 100-count and 500-count bottle sizes. The contract aims to ensure a continuous supply of these essential medications to serve the beneficiary populations of the participating federal agencies.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $0 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 36E79721D0026?
36E79721D0026 was awarded to Radha Pharmaceuticals Inc. by National Acquisition Center (Headquarters) on August 1, 2021.
How much is contract 36E79721D0026 worth?
36E79721D0026's own ceiling is $13,398,315.
Who can order from contract 36E79721D0026?
36E79721D0026 is a single award indefinite delivery contract.
Was contract 36E79721D0026 competed?
The extent of competition for 36E79721D0026 was full and open competition. The government received 3 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV